No abstract available
Keywords:
BAFF; Belimumab; Lupus nephritis; Rituximab; SLE.
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Antineoplastic Agents, Immunological / therapeutic use
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Drug Therapy, Combination
-
Female
-
Follow-Up Studies
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Lupus Erythematosus, Systemic / diagnosis
-
Lupus Erythematosus, Systemic / drug therapy*
-
Rituximab / therapeutic use*
-
Severity of Illness Index
-
Treatment Outcome
-
Young Adult
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
Immunosuppressive Agents
-
Rituximab
-
belimumab